Abstract
Scaling up of suspension dosage form is considered a challenge as pharmaceutical suspensions are thermodynamically unstable. During the scale-up process, the effect of operational variables on the dispersion process, and physical properties affecting overall attributes need systematic evaluation. Though the scale up process can be studied using dimensional analysis, mathematical modeling, and computer simulation, most of the work in the field of suspension manufacturing still depends on empirical studies and the principles of geometric similarities. Various aspects of the scale up process, technology transfer, and process analytical technology (PAT) applications in suspension manufacturing are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barthe, S. and Rousseau, R.W., 2006, Utilization of focused beam reflectance measurement in the control of crystal size distribution in a batch cooled crystallizer, Chem. Eng. Technol., 29, 206–211.
Blanco, A., Fuente, E., Negro, C. and Tijero, J., 2002, Flocculation monitoring: FBRM as a measurement tool, Can. J. Chem. Eng., 80, 1–7.
Block, L.H., 2002, Non parenteral Liquids and semisolids, In Pharmaceutical scale up, 57–94, Editor; Levin, M., New York, Marcel Dekker Inc.
Caballero, F.G. and Duran, J.L., 2000, Suspension formulation, In Pharmaceutical Emulsions and suspensions, 127–190, New York, Marcel Dekker Inc.
Charpentier, J.C., 2003, Market demand versus technological development: the future of chemical engineering, Int. J. Chem. Reactor Eng., A14.
FDA Document, 1999, Container, closure systems for packaging human drugs and bilogis, chemistry, manufacturing and control documentation, May.
FDA Document, 2006, Guide to inspections oral solutions and suspensions.
Gallardo, V., Ruiz, M. and Delgado, A., 2000, Pharmaceutical suspensions: their applications, 409–464, New York, Marcel Dekker Inc.
Gruverman, I.J., 2003, Breakthrough ultraturbulant reaction thechnology opens frontier for developing life saving nanometer scale suspensions, Drug Deliv. Technol., 3, 52–55
Gruverman, I.J., 2004, A drug delivery breakthrough-nanosuspension formulations for intravenous, oral and transdermal administration of active pharmaceutical ingredients, Drug Deliv. Technol., 4, 58–59.
Gruverman, I.J., 2005, Nanosuspension preparation and formulation, Drug Deliv. Technol., 5, 71–75.
Heath, A.R., Fawell, P.D., Bahri, P.A. and Swift, J.D., 2002, Estimating average particle size by FBRM, Part. Part. Syst. Charact., 19, 84–95.
Joseph, J.A., 2005, Over coming the challenges of blending multiple component dietary supplements, Tablets and Capsule, July, 38–42.
Karanth, H., Shenoy, V.S. and Murthy, R.R., 2006, Industrially feasible alternative approaches in the manufacture of solid dispersions: A technical report, AAPS PharmSciTech, 7, E1–E8.
Kidder, L.H., Lee, E. and Lewis, E.N., 2005, NIR chemical imaging as a process analytical tool, Innovations in Pharmaceutical Technology September, 107–111.
Kougoulas, E., Jones, A.G., Jennings, K.H. and Wood-Kaczmar, M.W., 2005, Use of FBRM and process video imaging in a modified mixed suspension mixed product removal coling crystallizer, 273, 529–534.
Laitinin, N., Antikainin, O. and Yliruusi, J., 2003, Characterization of particle size in bulk pharmaceutical solids using digital image information, AAPS PharmSciTech, 4, 383–387.
Lasinski, M.E., Nere, N.K., Hamilton, R.A., James, B.D. and Curtis, J.S., 2005, Error analysis of FBRM, Poster, presented at Particle technology Forum Poster session, Nov 1st 2005, Cincinnati, OH, no. 287 b.
Lewis, E.N., Schoppelrei, J.W., Lee, E. and Kidder, L.H., 2005, NIR chemical imaging as a process analytical tool. In Process analytical technology, Chapter 7, 187, Editors; Bakeev, K., Blackwell Publishing.
Liu, J., 2006, Physical characterization of pharmaceutical formulations in frozen and freeze dried solid states: Techniques and applications in freeze drying development, Pharm. Dev. Technol., 11, 3–28.
Lu, G.W. 2007, Development of oral suspensions, Am. Pharm. Rev., 10, 35–37.
Levin, M., 2005, How to scale up scientifically: Scale up manufacturing, Pharm. Techol., S4–S12.
Nash, R.A., 1996, Pharmaceutical suspensions, In Pharmaceutical dosage forms: disperse systems, Volume 2, 1–46, Editors; Lieberman, H.A., Rieger, M.M. and Banker, G.S., Marcel Dekker, New York.
Newton, J.M., Chapman, S.R. and Rowe, R.C., 1995, The assessment of scale up performance of the extrusion-spheronization process, Int. J. Pharm., 120, 95–99.
Mehta, A.M., 1988, Scale –up considerations in the fluid bed process for controlled release products, 12, 46–54.
Paul, E.L., Midler, M. and Sun, Y., 2004, Mixing in the fine chemicals and pharmaceutical industries, In Handbook of industrial mixing, Editors; Paul, E.L., Obeng, V.A.A. and Kresta, S.M., New York, John Wiley and Sons.
Rabinow, B., 2005, Pharmacokinetics of drug administered in nanosuspension, Disc. Med., 5, 74–79.
Rabinow, B., 2007, Parenteral nanosuspensions, In Nanoparticulate drug delivery systems, Editors; Thassu, D., Deleers, M. and Pathak, Y.V., Infroma Healthcare, New York.
Radspinner, D., Davies, B. and Kamal, Z., 2005, Process analytical technology and outsourcing-impacts on manufacturing and process knowledge, GOR, 7(4), 55–58.
Saarimaa, V., Sundberg, A. and Holmbom, B., 2006, Monitoring of dissolved air flotation by FBRM, Ind. Eng. Chem. Res., 45, 7256–7263.
Sekulic, S.S., 2007, Is PAT changing the product and process development? Am. Pharm. Rev., 10, 30–34.
Shaw G., 2005, Micrograms to Kilograms: the challenge of scaling, Drug Discovery and Development, July, 1–4.
Sohi, H., Sultana, Y. and Khar, R., 2004, Taste masking technologies in oral pharmaceuticals: Recent developments and approaches, Drug Dev. Ind. Pharm., 30, 429–448.
Vaccaro, A., Sercik, J. and Morbidelli, M., 2006, Modelling focused beam reflectance measurement (FBRM) and its application to sizing of the particles of variable shape, Part. Part. Syst. Charact., 23, 360–373.
Wibowo, C. and Ng, K.M., 2004, Product oriented process synthesis: Creams and pastes, AIChE J., 47, 2746–2767.
Zlokarnik, M., 2002, Dimensional analysis and scale up in theory and industrial application, 1–41, In Pharmaceutical scale up, 57–94, Editor; Levin, M., New York, Marcel Dekker Inc.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 AAPS
About this chapter
Cite this chapter
Pathak, Y., Thassu, D. (2010). Scale Up and Technology Transfer of Pharmaceutical Suspensions. In: Kulshreshtha, A., Singh, O., Wall, G. (eds) Pharmaceutical Suspensions. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1087-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1087-5_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1086-8
Online ISBN: 978-1-4419-1087-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)